KE LIU, MD
Emergency Medical Service in Charlotte Hall, MD
License number
Maryland D0055265
Category
Emergency Medical Service
Type
Personal Emergency Response Attendant
Address
Address
2
37767 MARY'S Med. Ctr, Charlotte Hall, MD 20622
14 Sweetwood Ct, Rockville, MD 20850
14 Sweetwood Ct, Rockville, MD 20850
Phone
(301) 475-5910
Professional information
Ke E Liu, Charlotte Hall MD
Specialties:
Internist
Address:
37767 Market Dr, Charlotte Hall, MD 20622
Education:
Henan Medical University - Doctor of Medicine
National Institutes of Health-Clinical Center - Fellowship - Oncology (Internal Medicine)
Long Island Jewish Medical Center - Residency - Internal Medicine
National Institutes of Health-Clinical Center - Fellowship - Oncology (Internal Medicine)
Long Island Jewish Medical Center - Residency - Internal Medicine
Board certifications:
American Board of Internal Medicine Certification in Internal Medicine, American Board of Internal Medicine Sub-certificate in Oncology (Internal Medicine)
Dr. Ke Liu, Charlotte Hall MD - MD (Doctor of Medicine)
Specialties:
Oncology, Medical Oncology
Address:
37767 Market Dr, Charlotte Hall 20622
(301) 475-5910 (Phone)
(301) 475-5910 (Phone)
Certifications:
Internal Medicine, 1999, Medical Oncology, 2011
Awards:
Healthgrades Honor Roll
Languages:
English
Education:
Medical School
Henan U Med Coll
Long Island Jewish Medical Center
National Institutes Of Health-Clinical Center
Henan U Med Coll
Long Island Jewish Medical Center
National Institutes Of Health-Clinical Center
Methods Of Preparing Lymphocytes That Express Interleukin-2 And Their Use In The Treatment Of Cancer
US Patent:
7381405, Jun 3, 2008
Filed:
Oct 15, 2002
Appl. No.:
10/531145
Inventors:
Ke Liu - Rockville MD, US
Steven A. Rosenberg - Potomac MD, US
Steven A. Rosenberg - Potomac MD, US
Assignee:
The United States of America as represented by the Department of Health and Human Services - Washington DC
International Classification:
A01N 63/00, A61K 39/00, C12N 15/00, C12N 15/63, C07H 21/04
US Classification:
424 9321, 4353201, 435325, 435455, 536 235, 536 241, 4241841
Abstract:
The invention provides methods of preparing autologous T-lymphocytes for re-introduction into a patient having cancer, which method comprises obtaining peripheral blood mononuclear cells (PBMCs) from a patient immunized with an antigen of the cancer, stimulating the PBMCs with the antigen of the cancer in vitro, transducing the PBMCs with a retroviral vector, which (a) comprises and expresses a human interleukin-2 (IL-2) coding sequence operably linked to a retroviral promoter, (b) does not comprise an exogenously introduced gene that enables phenotypic selection, and (c) comprises a viral envelope that efficiently transduces CD8+ T-lymphocytes; compositions comprising cells obtained in accordance with such methods; and methods of treating a patient having cancer by administering to the patient cells obtained in accordance with such methods or compositions comprising same.